|
JOURNAL PUBLICATIONS Google Scholar (H index = 37 ; citations 3818) 2023 Elmira Ziaei, Igor Moura de Paiva, Shih-Jing Yao, Nasim Sarrami, Parnian Mehinrad, Justine Lai, Afsaneh Lavasanifar*, Kamaljit Kaur*, Peptide-Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice, Mol. Pharm., 2023, 20, 3570-3577. PubMed Link 2022 Oluseye Ogunnigbagbe, Christopher G. Bunick*, Kamaljit Kaur*, Keratin 1 as a cell-surface receptor in cancer, Biochimica et Biophysica Acta (BBA) – Reviews on Cancer 2022, 1877, 188664. PubMed Link S. Tong, S. Darwish, H. H. Nejad Ariani, K. A. Lozada, D. Salehi, M. A. Cinelli, R. B. Silverman, K. Kaur*, S. Yang*, A small peptide increases drug delivery in human melanoma cells, Pharmaceutics 2022, 14, 1036. PubMed Link 2021 M. Alas, A. Saghaeidehkordi, K. Kaur*, Peptide-Drug Conjugates with Different Linkers for Cancer Therapy, J. Med. Chem. 2021, 64, 216-232. PubMed Link Azam Saghaeidehkordi, Shiuan Chen, Sun Yang, Kamaljit Kaur*, Evaluation of a keratin 1 targeting peptide-doxorubicin conjugate in a mouse model of triple-negative breast cancer, Pharmaceutics 2021, 13, 661. PubMed Link Harpreet Dhingra, Kamaljit Kaur, Baljit Singh*, Engineering and characterization of human β-defensin-3 and its analogues and microcin J25 peptides against Mannheimia haemolytica and bovine neutrophils, Vet. Res. 2021, 52, 83. 2019 E. Ziaei, A. Saghaeidehkordi, C. Dill, I. Maslennikov, S. Chen, K. Kaur*, Targeting Triple Negative Breast Cancer Cells with Novel Cytotoxic Peptide-Doxorubicin Conjugates, Biocon. Chem., 2019, 30, 3098-3106. PubMed Link R. Soudy, R. Kimura, A. Patel, W. Fu, K. Kaur, D. Westaway, J. Yang, J. Jhamandas*, Short amylin receptor antagonist peptides improve memory deficits in Alzheimer’s disease mouse model, Sci. Rep. (Nature Publishing Group), 2019, 9, 10942:1-11. PubMed Link H. Hossein-Nejad-Ariani, E. Althagafi, K. Kaur*, Small peptide ligands for targeting EGFR in triple negative breast cancer cells, Sci. Rep. (Nature Publishing Group), 2019, 9, 2723:1-10. PubMed Link 2018 S.B. Patil, R.M. Al-Jehani, H. Etayash, V. Turbe, K. Jiang, J. Bailey, W. Al-Akkad, R. Soudy, K. Kaur, R.A. McKendry, T. Thundat, J.W. Ndieyira*, Modified cantilever arrays improve sensitivity and reproducibility of nanomechanical sensing in living cells, Commun. Biol. (Nature Publishing Group) 2018, 1, 175. PubMed Link H. Soleymani Abyaneh, A.H. Soleimani, M.R. Vakili, R. Soudy, K. Kaur, F. Cuda, A. Tavassoli, A. Lavasanifar*, Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance, Pharmaceutics, 2018, 10, 196. PubMed Link W. Mohammed-Saeid, R. Soudy, R. Tikoo, K. Kaur, R. Verrall, I. Badea*, Design and evaluation of gemini surfactant-based lipoplexes modified with cell-binding peptide for targeted gene therapy in melanoma model, J. Pharm. Pharm. Sci., 2018, 21, 363-375. PubMed Link Hanieh Hossein-Nejad-Ariani, Tushar Kim, K. Kaur*, Peptide-based Biosensor Utilizing Fluorescent Gold Nanoclusters for Detection of Listeria monocytogenes, ACS Appl. Nano Mater. 2018, 1, 3389-3397. PubMed link 2017 W. Fu, V. Vukojevic, A. Patel, R. Soudy, D. MacTavish, D. Westaway, K. Kaur, V. Goncharuk, J. Jhamandas*, Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation, J. Neuroinflammation, 2017, 14, 199 (1-12). PubMed Link D.R. Balay, R.V. Dangeti, K. Kaur, L.M. McMullen*, Purification of leucocin A for use on wieners to inhibit Listeria monocytogenes in the presence of spoilage organisms, Int. J. Food Microbiol., 2017, 255, 25-31. PubMed Link S.M. Garg, I.M. Paiva, M.R. Vakili, R. Soudy, K. Agopsowicz, A.H. Soleimani, M. Hitt, K. Kaur, A. Lavasanifar*, Traceable PEO-poly(ester) micelles for breast cancer targeting: The effect of core structure and targeting peptide on micellar tumor accumulation, Biomaterials 2017, 144, 17-29. PubMed Link Y. Raghuwanshi, H. Etayash, R. Soudy, I. Paiva, A. Lavasanifar, K. Kaur*, Proteolytically stable cyclic decapeptide for breast cancer cell targeting, J. Med. Chem. 2017, 60, 4893-4903. PubMed link R. Soudy, H. Etayash, K. Bahadorani, A. Lavasanifar, K. Kaur*, Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer, Mol. Pharm., 2017, 14, 593-604. PubMed link P.M. Shaibani, H. Etayash, S. Naicker, K. Kaur, T. Thundat*, Metabolic Study of Cancer Cells using a pH Sensitive Hydrogel Nanofiber Light Addressable Potentiometric Sensor (NF-LAPS), ACS Sens. 2017, 2, 151-156. R. Soudy, A. Patel, W. Fu, K. Kaur, D. MacTavish, D. Westaway, R. Davey, J. Zajac, J. Jhamandas*, Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer’s Disease, Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2017, 3, 44-56. 2016 H. Etayash, M.F. Khan, K. Kaur*, T. Thundat*, Microfluidic cantilever detects bacteria and measures their susceptibility to antibiotics in small confined volumes, Nature Comm. 2016, 12947. PubMed link H. Etayash, A.R. McGee, K. Kaur, T. Thundat*, Nanomechanical sandwich assay for multiple cancer biomarkers in breast cancer cell-derived exosomes, Nanoscale 2016, 15137. PubMed link K. Kaur*, O. Tarassova, R.V. Dangeti, S. Azmi, D. Wishart, L. McMullen, M. Stiles, Characterization of a highly potent antimicrobial peptide microcin N from Uropathogenic Escherichia coli, FEMS Microbiol. Lett. 2016, 363. PubMed link R. Soudy, N. Byeon, Y. Raghuwanshi, S. Ahmed, A. Lavasanifar, K. Kaur*, Engineered Peptides for Applications in Cancer Targeted Drug Delivery and Tumor Detection, Mini Rev. Med. Chem., 2016, 16. PubMed link 2015 H. Etayash, K. Jaing, S. Azmi, T. Thundat, K. Kaur*, Real-time Detection of Breast Cancer Cells Using Peptide-functionalized Microcantilever Arrays, Sci. Rep. (Nature Publishing Group), 2015, 5, 13967:1-13. PubMed link K. Jiang, H. Etayash, S. Azmi, S. Naicker, M. Hassanpourfard, P.M. Shaibani, G. Thakur, K. Kaur, T. Thundat*, Rapid Label-free Detection of E. coli using Antimicrobial Peptide Assisted Impedance Spectroscopy, Anal. Methods, 2015, 7, 9744-9748. Link H. Etayash, S. Azmi, R. Dangeti, K. Kaur*, Peptide Bacteriocins – Structure Activity Relationships, Curr. Top. Med. Chem., 2015, 16, 220-241. PubMed link H. Trzeciakiewicz, J. Esteves-Villanueva, R. Soudy, K. Kaur, S. Martic-Milne*, Electrochemical Characterization of Protein Adsorption onto YNGRT-Au and VLGXE-Au Surfaces, Sensors, 2015, 15, 19429-19442. PubMed link M. H. Gilzad-Kohan*, K. Kaur, and F. Jamali, Synthesis and characterization of a new peptide prodrug of glucosamine with enhanced gut permeability, PLoS One, 2015, 10(5), e0126786. PubMed link S. Azmi, K. Jiang, T. Thundat, K. Kaur*, Detection of Listeria monocytogenes with short peptide fragments from class IIa bacteriocins as recognition elements, ACS Comb. Sci., 2015, 17, 156-163. PubMed link 2014 K. Kaur*, S. Bhattacharjee, R. Pillai, S. Ahmed, S. Azmi, Peptide Arrays for Detecting Naphthenic Acids in Oil Sands Process Affected Water, RSC Advances, 2014, 4, 60694-60701. Link S. Ahmed, T. Sprules, and K. Kaur*, Structural similarity between b3-Peptides synthesized from and b3-homo-amino acids and L-aspartic acid monomers, Biopolymers (Peptide Science). 2014, 102, 359-367. PubMed link N.S.K. Gunda, M. Singh, L. Norman, K. Kaur, and S.K. Mitra*, Optimization and characterization of biomolecule immobilization on silicon substrates using (3-aminopropyl)triethoxysilane (APTES) and glutaraldehyde link, Applied Surface Science. Microdevices, 2014, 305, 522-530. H. Etayash, K. Jaing, T. Thundat, K. Kaur*, Impedimetric Detection of Pathogenic Gram-Positive Bacteria using An Antimicrobial Peptide from Class IIa Bacteriocins, Anal. Chem., 2014, 86, 1693-1700. PubMed link H. Etayash, L. Norman, T. Thundat, M. Stiles, K. Kaur*, Surface Conjugated Antimicrobial Peptide Leucocin A Displays High Binding to Pathogenic Gram-positive Bacteria, ACS Appl. Mater. Interfaces, 2014, 6, 1131-1138. PubMed link 2013 R. Soudy, C. Chen, and K. Kaur*, Novel Peptide-Doxorubicin Conjugates for Targeting Breast Cancer Cells including the Multidrug Resistant Cells, J. Med. Chem., 2013, 56, 7564-7573. PubMed link M. H. Gilzad-Kohan, K. Kaur, and F. Jamali*, The Antiinflammatory Action and Pharmacokinetics of a Novel Di-Peptide Aminosugar, J. Pharm. Pharm. Sci., 2013, 16, 279-288. PubMed link N.S.K. Gunda, M. Singh, Y. Purwar, S.L. Shah, K. Kaur, and S.K. Mitra*, Micro-spot with Integrated Pillars (MSIP) for Detection of Dengue Virus NS1, Biomed. Microdevices, 2013, 15, 959-971. PubMed link A.S. Mathews, S. Ahmed, M. Shahin, A. Lavasanifar and K. Kaur*, Peptide modified Polymeric Micelles Specific for Breast Cancer Cells, Bioconjugate Chemistry, 2013, 24, 560-570. PubMed link K. Bodapati, R. Soudy, H. Etayash, and K. Kaur*, Design, Synthesis and Evaluation of Antimicrobial Peptide Leucocin A Analogues with N-Terminal b-Sheet Replaced by a β-Turn Sequence, Bioorg. Med. Chem., 2013, 21, 3715-3722. PubMed link H. Etayash, L. Norman, T. Thundat, K. Kaur*, Peptide-Bacteria Interactions using Engineered Surface Immobilized Peptides from Class IIa Bacteriocins, Langmuir, 2013, 29, 4048-4056. PubMed link A. Sohrabi, P.M. Shaibani, H. Etayash, K. Kaur, T. Thundat, Sustained drug release and antibacterial activity of ampicillin incorporated poly(methyl methacrylate)–nylon6 core/shell nanofibers, Polymer, 2013, 54, 2699-2705. Link M. Shahin, R. Soudy, H.M. Aliabadi, N. Kneteman, K. Kaur, A. Lavasanifar*, Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity, Biomaterials 2013, 34, 4089-4097. PubMed link 2012 R. Soudy, S. Ahmed and K. Kaur*, NGR Peptide Ligands for Targeting CD13/APN Identified through Peptide Array Screening Resemble Fibronectin Sequences, ACS Combinatorial Science, 2012, 14, 590-599. M. Shahin, R. Soudy, H. El-Sikhry, J.M. Seubert, K. Kaur, A. Lavasanifar*, Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin, Cancer Lett. 2012, in press. D. Raghuwanshi, V. Mishra, M.R. Suresh, K. Kaur*, A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles, Vaccine, 2012, 30, 7292-7299. R. Soudy, L. Wang, and K. Kaur, Synthetic Peptides derived from the Sequence of a Lasso Peptide Microcin J25 show Antibacterial Activity, Bioorg. Med. Chem., 2012, 20, 1794-1800. D. Raghuwanshi, V. Mishra, D. Das, K. Kaur, and M.R. Suresh, Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein, Protein, Mol. Pharmaceutics 2012, 9, 946-956. R. Soudy, A. Gill, T. Sprules, A. Lavasanifar, and K. Kaur, Proteolytically Stable Cancer Targeting Peptides with High Affinity for Breast Cancer Cells, J. Med. Chem., 2011, 54, 7523-7534. M. Shahin, S. Ahmed and K. Kaur, A. Lavasanifar, Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel, Biomaterials, 2011, 32, 5123-5133. W. Soliman, L. Wang, S. Bhattacharjee, and K. Kaur, Structure-activity relationships of an antimicrobial peptide Plantaricin S from two-Peptide class IIb bacteriocins, J. Med. Chem., 2011, 54, 2399-2408. 1997-2010 S. Ahmed, A.S. Mathews, N. Byeon, A. Lavasanifar, K. Kaur, Peptide Arrays for Screening Cancer Specific Peptides. Anal. Chem., 2010, 82, 7533-7541. W. Soliman, S. Bhattacharjee, and K. Kaur, Adsorption of an Antimicrobial Peptide on Self-Assembled Monolayers by Molecular Dynamics Simulation, J. Phys. Chem. B 2010, 114, 11292-11302. W. Soliman, S. Bhattacherjee, K. Kaur, Interaction of an antimicrobial Peptide with a model lipid bilayer using molecular dynamics simulation, Langmuir 2009, 25, 6591-6595. S. Ahmed and K. Kaur, The proteolytic stability and cytotoxicity studies of L-aspartic acid and L-diaminopropionic acid derived b-peptides and a mixed a/b-peptide, Chem. Biol. Drug Des., 2009, 73, 545-552. R. Beleid, D. Douglas, N. Kneteman, K. Kaur, Helical peptides derived from lactoferrin bind hepatitis C virus envelope protein E2, Chem. Biol. Drug Des., 2008, 72, 436-443. K. Kaur, T. Sprules, W. Soliman, R. Beleid, S. Ahmed, Right-handed 14-helix in b3-peptides from L-aspartic acid monomers, Biochim. Biophys. Acta 2008, 1784, 658-665. W. Soliman, S. Bhattacherjee, K. Kaur, Molecular dynamics simulation study of interaction between a class IIa bacteriocin and its immunity protein, Biochim. Biophys. Acta 2007, 1774, 1002-1013. S. Ahmed, R. Beleid, T. Sprules, and K. Kaur, Solid-phase synthesis and CD spectroscopic investigations of novel b-peptides from L-aspartic acid and b-amino-L-alanine, Org. Lett. 2007, 9, 25-28. L.J. Gursky, N.I. Martin, D.J. Derksen, M.J. Van Belkum, K. Kaur, J.C. Vederas, M.E. Stiles, L.M. McMullen, Production of piscicolin 126 by Carnobacterium maltaromaticum UAL26 is controlled by temperature and induction peptide concentration, Arch. Microbiol. 2006, 186, 317-325. K. Kaur, L.C. Andrew, D.S. Wishart, and J.C. Vederas, Dynamic relationships among type IIa bacteriocins: Temperature effects on antimicrobial activity and on structure of the C-terminal amphipathic a-helix as a receptor binding region, Biochemistry 2004, 43, 9009-9020. N.R. Silvaggi, K. Kaur, S.A. Adediran, R.F. Pratt, and J.A. Kelly, Toward better antibiotics: Crystallographic studies of a novel class of DD-peptidase/b-lactamase inhibitors, Biochemistry 2004, 43, 7046-7053. K. Kaur, S.A. Adediran, M.J.K. Lan, and R.F. Pratt, Inhibition of b-lactamases by monocyclic acyl phosph(on)ates, Biochemistry 2003, 42, 1529-1536. K. Kaur, M.J.K. Lan, and R.F. Pratt, Mechanism of inhibition of the class C b-lactamase of Enterobacter cloacae P99 by cyclic acyl phosph(on)ates: Rescue by return, J. Am. Chem. Soc. 2001, 123, 10436-10443. K. Kaur and R.F. Pratt, Mechanism of reaction of acyl phosph(on)ates with the b-lactamase of Enterobacter Cloacae P99, Biochemistry 2001, 40, 4610-4621. R.G. Salomon, K. Kaur, and E. Batyreva, Isolevuglandin-protein adducts in oxidized low density lipoprotein and human plasma: A strong connection with cardiovascular disease, Trends Cardiovasc. Med. 2000, 10, 53-59. R.G. Salomon, K. Kaur, E. Podrez, H.F. Hoff, A.V. Krishinsky, L.M. Sayre, HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques, Chem. Res. Toxicol. 2000, 13(7), 557-564. R.G. Salomon, E. Batyreva, K. Kaur, D. Sprecher, M.J. Schreiber, J.W. Crabb, M.S. Penn, A.M. DiCorleto, S.L. Hazen, E.A. Podrez, Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway, Biochim. Biophys. Acta 2000, 1485(2-3), 225-235. R.G. Salomon, W. Sha, C. Brame, K. Kaur, G. Subbanagounder, J. O’Neil, H.F. Hoff and L.J. Roberts II, Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein, J. Biol. Chem. 1999, 274(29), 20271-20280. K. Kaur, R.G. Salomon, J. O’Neil, and H.F. Hoff, Carboxyalkyl pyrroles in human plasma and oxidized low density lipoproteins, Chem. Res. Toxicol. 1997, 10(12), 1387-1396. R.G. Salomon, G. Subbanagounder, J. O’Neil, K. Kaur, M.A. Smith, H.F. Hoff, G. Perry, and V.M. Monnier, Levuglandins E2-protein adducts in human plasma and vasculature, Chem. Res. Toxicol. 1997, 10(5), 536-545. L.M. Sayre, W. Sha, G. Xu, K. Kaur, D. Nadkarni, G. Subbanagounder, and R.G. Salomon, Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal, Chem. Res. Toxicol. 1996, 9(7), 1194-1201. Y.D. Vankar, G. Kumaravel, I. Bhattacharya, P.S. Vankar, and K. Kaur, Reactions of 2-phenylthio-2-cycloalkenones and 2-[phenyl(thiomethyl)]-2-cycloalkenones: Synthesis of some useful chiral and achiral intermediates, Tetrahedron 1995, 51, 4829-4840. |